NASS 2017 Annual Meeting

Frank Cammisa Jr., MD




Device or Biologic Distributorship (Physician-Owned Distributorship): Alphatec (B); Royalties: NuVasive (C); Stock Ownership: Alphatec Spine (88021 Shares), NuVasive (14580 Shares), Paradigm Spine (<1%), Small Bone Innovations (<1%), Spinal Kinetics (20000 Shares); Private Investments: Ivy Healthcare I and II (B), Woven Orthopedic Technologies (F), Royer Biomedical (E), Promethean Surgical Devices (D), Liventa Bioscience (E), BioAssets Development Corporation (Amount not disclosed), Bonovo Orthopedic (C), HealthpointCapital Partners (C), NuVasive (Common Shares), BI Members (C), MMF Systems (None), Viscogliosi Brothers Venture Partners III (C); Consulting: Alphatec Spine (B), Vertical Spine (Stock options), NuVasive (Common Shares), Paradigm Spine (Stock Ownership disclosed), DePuy Synthes (A), Spinal Partners III (Consulting disclosed), Spinal Kinetics (B); Scientific Advisory Board: Alphatec (Common Stock), Spine Partners III (Medical Advisory Board), Spinal Kinetics (Stock Options, Common Stock), Paradigm Spine (Stock Options), HealthpointCapital Partners (Private Investments disclosed), Ivy Healthcare Partners (Private Investments disclosed); Research Support - Staff and/or Materials: Spinal Kinetics (C, Paid directly to institution/employer), DePuy (E, Paid directly to institution/employer), Bacterin (F, Paid directly to institution/employer), Integra (F, Paid directly to institution/employer), NuTech (F, Paid directly to institution/employer), Vertical Spine (E, Paid directly to institution/employer); Fellowship Support: NuVasive (E, Paid directly to institution/employer).

Sessions :